[go: up one dir, main page]

GB1417119A - Process for treating bones - Google Patents

Process for treating bones

Info

Publication number
GB1417119A
GB1417119A GB5544472A GB5544472A GB1417119A GB 1417119 A GB1417119 A GB 1417119A GB 5544472 A GB5544472 A GB 5544472A GB 5544472 A GB5544472 A GB 5544472A GB 1417119 A GB1417119 A GB 1417119A
Authority
GB
United Kingdom
Prior art keywords
fatty acid
sodium
acid
bone fractures
carrier
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB5544472A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB5544472A priority Critical patent/GB1417119A/en
Publication of GB1417119A publication Critical patent/GB1417119A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/20Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/21Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/23Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin of acids having a carboxyl group bound to a chain of seven or more carbon atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Emergency Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

1417119 Treating bone fractures G H THIELE 30 Nov 1972 55444/72 Heading ASB Bone fractures may be healed by local injection of a liquid of pH 8-11 comprising (a) a salt or ester of formic acid, an alkane carboxylic acid, an unsaturated fatty acid, a hydroxy-substituted fatty acid, a hydrogenated fatty acid or a polymerised fatty acid and (b) a liquid carrier. Salts specified include sodium morrhuate, ethylammonium oleate, sodium psyllicate and sodium ricinoleate. The carrier is usually water and may also contain ethanol, benzyl alcohol and sodium hydroxide. Where necessary, the bones are aligned before treatment and several doses of the composition may be administered over a period. The treatment is applied to the coffin 'bone of a horse.
GB5544472A 1972-11-30 1972-11-30 Process for treating bones Expired GB1417119A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
GB5544472A GB1417119A (en) 1972-11-30 1972-11-30 Process for treating bones

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5544472A GB1417119A (en) 1972-11-30 1972-11-30 Process for treating bones

Publications (1)

Publication Number Publication Date
GB1417119A true GB1417119A (en) 1975-12-10

Family

ID=10473924

Family Applications (1)

Application Number Title Priority Date Filing Date
GB5544472A Expired GB1417119A (en) 1972-11-30 1972-11-30 Process for treating bones

Country Status (1)

Country Link
GB (1) GB1417119A (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529081A1 (en) * 1982-06-28 1983-12-30 Mochida Pharm Co Ltd THERAPEUTIC COMPOSITION BASED ON 5-HYDROXYDECANOIC ACID OR A DERIVATIVE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
FR2573653A1 (en) * 1984-11-23 1986-05-30 Pf Medicament Antiandrogen pharmaceutical compositions based on fatty acids
EP0517425A1 (en) * 1991-06-05 1992-12-09 Efamol Holdings Plc Fatty acids for the reduction of urinary calcium excretion and the treatment of osteoporosis
EP0585026A1 (en) * 1992-08-21 1994-03-02 Scotia Holdings Plc Use of fatty acids for increasing gut calcium absorption
US5888541A (en) * 1992-08-21 1999-03-30 Scotia Holdings Plc Fatty acid treatment

Cited By (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2529081A1 (en) * 1982-06-28 1983-12-30 Mochida Pharm Co Ltd THERAPEUTIC COMPOSITION BASED ON 5-HYDROXYDECANOIC ACID OR A DERIVATIVE THEREOF FOR THE TREATMENT OF CARDIOVASCULAR DISEASES
NL8302273A (en) * 1982-06-28 1984-01-16 Mochida Pharm Co Ltd THERAPEUTIC PREPARATION FOR TREATING HEART DISEASE.
US4578400A (en) * 1982-06-28 1986-03-25 Mochida Pharmaceutical Co., Ltd. Therapeutic composition and method for treatment of cardiovascular diseases
FR2573653A1 (en) * 1984-11-23 1986-05-30 Pf Medicament Antiandrogen pharmaceutical compositions based on fatty acids
EP0517425A1 (en) * 1991-06-05 1992-12-09 Efamol Holdings Plc Fatty acids for the reduction of urinary calcium excretion and the treatment of osteoporosis
US5318991A (en) * 1991-06-05 1994-06-07 Efamol Holdings Plc Fatty acid treatment to reduce calcium excretion
EP0585026A1 (en) * 1992-08-21 1994-03-02 Scotia Holdings Plc Use of fatty acids for increasing gut calcium absorption
US5618558A (en) * 1992-08-21 1997-04-08 Scotia Holdings Plc Fatty acid treatment
US5888541A (en) * 1992-08-21 1999-03-30 Scotia Holdings Plc Fatty acid treatment
SG80536A1 (en) * 1992-08-21 2001-05-22 Scotia Holdings Plc Use of fatty acids for increasing gut calcium absorption

Similar Documents

Publication Publication Date Title
GB1440386A (en) Tratment of mosaic bone fractures of the bone and periosteum in non-human animals
ES2168334T3 (en) COMPOSITION FOR SKIN TREATMENT.
BE878772A (en) PROCESS FOR THE PREPARATION OF SILVER SALTS OF ORGANIC CARBOXYLIC ACIDS
US3741204A (en) Method of trating bone fractures and non unions
GB1417119A (en) Process for treating bones
US3805776A (en) Treatment of non-surgical osteolysis of bone
CA945317A (en) Vaporizing apparatus for treatment of animal carcasses
ES404748A1 (en) Process for preparing injectionable compositions
FR1429208A (en) Process for the preparation of alkali salts of carboxylic acids
SE7905659L (en) MEANS FOR THE TREATMENT OF SEBORREIS CONDITIONS
ES388882A1 (en) 1-(2'-cyano-phenoxy)-2-hydroxy-3-ethylamino-propane and salts thereof
FR2390157A1 (en) PRODUCT AND PROCESS FOR THE TREATMENT OF DENTAL IVORY WITH CERIUM
US3828772A (en) Method of fusing bones
Freed et al. Therapeutic use of estrone suspensions
US3767812A (en) Non surgical removal of abnormal bone proliferation
ES344031A1 (en) A PROCEDURE FOR PRODUCING A COMPOSITION OF DL-METHIO-NINE.
GB1452263A (en) Amino acid process for its preparation and compositions thereof
ES8205787A1 (en) 7-oxoprostacyclin derivatives and process for the preparation thereof.
SU733683A1 (en) Antitrichomonas agent
ES8104214A1 (en) Procedure for the obtaining of active therapeutic derivatives of the 2,5-dihydroxy-bencensulphonic acid. (Machine-translation by Google Translate, not legally binding)
ES465630A1 (en) Tanning composition and process
AU6545580A (en) Solutions of canrenoic acid and furosemide salts
GB882952A (en) Process for preparing cyclohexylsulfamic acid and cyclohexylsulfamates
GB950498A (en) Vaccine or antigen compositions
GB1384937A (en) Method of producing gelatin

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee